Data published on ANG4043, anti-HER2 monoclonal antibody for treatment of brain metastases
Angiochem, a clinical stage biotechnology company creating and developing drugs that cross the blood-brain barrier, today announced the publication in Molecular Cancer Therapeutics demonstrating that ANG4043, a peptide-monoclonal ...
Dec 9, 2014
0
0